Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update. J Clin Oncol. 2021 12 10; 39(35):3938-3958.

View in: PubMed

subject areas

Antineoplastic Agents
Antineoplastic Agents, Hormonal
Female
Humans
Molecular Targeted Therapy
Poly(ADP-ribose) Polymerase Inhibitors
Practice Guidelines as Topic
Prognosis
Receptor, ErbB-2
Receptors, Estrogen
Receptors, Progesterone
Triple Negative Breast Neoplasms

authors with profiles

Rita Nanda